Recurrent Adult Soft Tissue Sarcoma Completed Phase 2 Trials for Saracatinib (DB11805)

IndicationStatusPhase
DBCOND0028931 (Recurrent Adult Soft Tissue Sarcoma)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00659360AZD0530 in Treating Patients With Recurrent Locally Advanced or Metastatic Soft Tissue SarcomaTreatment